Company: LIDRW
Filing Date: 2025-05-12
Form Type: POS AM
Source: 0000947871-25-000486
Chunk: 3

Company: AEye, Inc.
Filing Date: 2025-05-12
Form: POS AM
Chunk 3
---
 for a description of the transaction contemplated
by the Purchase Agreement and “Selling Stockholder” for additional information regarding New Circle.

Our registration of the securities covered by this
prospectus does not mean that New Circle will offer or sell any of the Common Stock. Subject to the terms of the Purchase Agreement, New
Circle may sell the shares of our Common Stock included in this prospectus in a number of different ways and at varying prices. We provide
more information about how New Circle may sell the shares in the section entitled “Plan of Distribution.” New Circle
is an “underwriter” within the meaning of Section 2(a)(11) of the Securities Act of 1933, as amended (the “Securities
Act”). Any profits on the sales of our Common Stock by New Circle and any discounts, commissions or concessions received by New
Circle may be deemed to be underwriting discounts and commissions under the Securities Act.

New Circle will pay all sales and brokerage commissions
and similar expenses in connection with the offer and resale of the Common Stock by New Circle pursuant to this prospectus. We will pay
the expenses (except sales and brokerage commissions and similar expenses) incurred in registering under the Securities Act the offer
and resale of the shares included in this prospectus by New Circle, including legal and accounting fees. See “Plan of Distribution.”

We are an “emerging growth company” as defined in Section
2(a) of the Securities Act, and are subject to reduced public company reporting requirements. This prospectus complies with the requirements
that apply to an issuer that is an emerging growth company.

Our Common Stock is listed on The Nasdaq Stock Market
LLC (“Nasdaq”) under the symbols “LIDR”. On May 8, 2025 , the closing price of our Common Stock was $ 0.56
per share.

<div align='center'>________________________</div>

Our business and investment in our Common Stock involve significant risks. These risks are described in the section titled “ Risk Factors” beginning on page 8 of this prospectus.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the accuracy or adequacy of this prospectus. Any representation to the contrary is a criminal offense.

<div align='center'>The date of this prospectus is May 9, 2025 .</div>

<div align='center'>TABLE OF CONTENTS</div>

| ABOUT THIS PROSPECTUS                           |